11 Best Inexpensive Stocks to Buy Now

Page 7 of 10

4. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 84

Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now. On January 20, Novavax announced a non-exclusive licensing agreement with Pfizer, granting the pharmaceutical giant access to its Matrix-M adjuvant tech. This technology is designed to boost immune responses to vaccines and will be utilized by Pfizer for up to two infectious diseases. While Pfizer will oversee the development, manufacturing, and commercialization of the resulting products, Novavax remains responsible for the delivery and supply of the Matrix-M adjuvant itself.

Earlier on January 10, Pfizer Inc. (NYSE: PFE) announced positive results from Cohort 3 of its pivotal BREAKWATER trial. This specific randomized cohort evaluated the BRAFTOVI regimen in combination with cetuximab and FOLFIRI for patients with previously untreated metastatic colorectal cancer harboring a BRAF V600E mutation.

The study showed that adding the chemotherapy backbone to the BRAFTOVI regimen significantly increased response rates. The analysis showed an objective response rate of 64% for the BRAFTOVI combination, compared to 39% for the standard-of-care treatment (FOLFIRI with or without bevacizumab). Pfizer noted these statistically significant results highlight potential flexibility in chemotherapy options for this patient population.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the US and internationally.

Page 7 of 10